Literature DB >> 19748786

Synthesis and pharmacological exploitation of clioquinol-derived copper-binding apoptosis inducers triggering reactive oxygen species generation and MAPK pathway activation.

Hui-Ling Chen1, Chun-Yi Chang, Hsun-Tzu Lee, Hua-Hsuan Lin, Pei-Jung Lu, Chia-Ning Yang, Chung-Wai Shiau, Arthur Y Shaw.   

Abstract

In the present study, we carried out Mannich-type reaction to synthesize clioquinol-derived 7-methyl-arylsulfonylpiperazine analogs with improved growth-inhibitory effects. 11 bearing 5-nitro group on the quinoline ring exhibited 26-fold more potent than that of clioquinol against HeLa cells with a GI(50) value of 0.71 microM. In addition, 11 revealed synergistic effects on the growth inhibition of HeLa cells with GI(50) values of 0.65, 0.25, and 0.06 microM in the presence of 1, 10, and 50 microM copper, respectively. Consistent to the clioquinol-mediated apoptosis, mechanistic study indicates that 9- and 11-induced growth inhibition is attributed to caspase-dependent pathway. Detection of reactive oxygen species in response to clioquinol, 9 and 11 confirmed that ROS was dramatically stimulated in the presence of copper and partially abolished upon treatment of 1mM tempol. Further study indicated that 9- and 11-mediated induction of oxidative stress by ROS generation resulted in the activation MAPK pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748786     DOI: 10.1016/j.bmc.2009.08.054

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

Review 1.  A high-content screening assay in transgenic zebrafish identifies two novel activators of fgf signaling.

Authors:  Manush Saydmohammed; Laura L Vollmer; Ezenwa Obi Onuoha; Andreas Vogt; Michael Tsang
Journal:  Birth Defects Res C Embryo Today       Date:  2011-09

2.  The antiparasitic clioquinol induces apoptosis in leukemia and myeloma cells by inhibiting histone deacetylase activity.

Authors:  Biyin Cao; Jie Li; Jingyu Zhu; Mingyun Shen; Kunkun Han; Zubin Zhang; Yang Yu; Yali Wang; Depei Wu; Suning Chen; Aining Sun; Xiaowen Tang; Yun Zhao; Chunhua Qiao; Tingjun Hou; Xinliang Mao
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

Review 3.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

4.  Profiling environmental chemicals for activity in the antioxidant response element signaling pathway using a high throughput screening approach.

Authors:  Sunita J Shukla; Ruili Huang; Steven O Simmons; Raymond R Tice; Kristine L Witt; Danielle Vanleer; Ram Ramabhadran; Christopher P Austin; Menghang Xia
Journal:  Environ Health Perspect       Date:  2012-05-02       Impact factor: 9.031

5.  Compound K, a metabolite of ginseng saponin, induces mitochondria-dependent and caspase-dependent apoptosis via the generation of reactive oxygen species in human colon cancer cells.

Authors:  In Kyung Lee; Kyoung Ah Kang; Chae Moon Lim; Ki Cheon Kim; Hee Sun Kim; Dong Hyun Kim; Bum Joon Kim; Weon Young Chang; Jae Hyuck Choi; Jin Won Hyun
Journal:  Int J Mol Sci       Date:  2010-12-01       Impact factor: 5.923

6.  A Proteomic View of Cellular Responses to Anticancer Quinoline-Copper Complexes.

Authors:  Bastien Dalzon; Joanna Bons; Hélène Diemer; Véronique Collin-Faure; Caroline Marie-Desvergne; Muriel Dubosson; Sarah Cianferani; Christine Carapito; Thierry Rabilloud
Journal:  Proteomes       Date:  2019-06-24

7.  Clioquinol induces pro-death autophagy in leukemia and myeloma cells by disrupting the mTOR signaling pathway.

Authors:  Biyin Cao; Jie Li; Xiumin Zhou; Jiaxiang Juan; Kunkun Han; Zubin Zhang; Yan Kong; Jianrong Wang; Xinliang Mao
Journal:  Sci Rep       Date:  2014-07-18       Impact factor: 4.379

8.  Synthesis and Cytoprotective Characterization of 8-Hydroxyquinoline Betti Products.

Authors:  Iván Kanizsai; Ramóna Madácsi; László Hackler; Márió Gyuris; Gábor J Szebeni; Orsolya Huzián; László G Puskás
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.